Ophthalmology

Explore the complexities of Ophthalmology research and treatment in China’s pharmaceutical industry. At Fineline Info & Tech, we provide reliable data, news, and insights to enhance your understanding and decision-making. Stay informed and stay ahead in the fight against Ophthalmology with flcube.com.

Biohaven Licenses MoDE Pan‑IgG Degrader Portfolio to Ono Pharmaceutical in Asia – Up to USD 100 Million in Near‑Term Payments for BHV‑1300 Franchise
CompanyDeals

Biohaven Licenses MoDE Pan‑IgG Degrader Portfolio to Ono Pharmaceutical in Asia – Up to USD 100 Million in Near‑Term Payments for BHV‑1300 Franchise

Biohaven Ltd. (NYSE: BHVN) announced that it has entered into a strategic licensing and collaboration agreement with Japan's Ono Pharmaceutical Co., Ltd. (TYO: 4528). Under the agreement, Ono will obtain…

Mirxes Partners with Thailand's National Cancer Institute on Blood‑Based Colorectal Cancer Screening – 2,000‑Subject Prospective Triage Study Backs "Cancer Moonshot 2056"

Mirxes Partners with Thailand’s National Cancer Institute on Blood‑Based Colorectal Cancer Screening – 2,000‑Subject Prospective Triage Study Backs “Cancer Moonshot 2056”

Huadong Medicine's Doer Bio Wins NMPA Clearance to Trial DR30206 – Tri‑Target PD‑L1/VEGF/TGF‑β Fusion Protein Advances into Stage III NSCLC Consolidation Therapy

Huadong Medicine’s Doer Bio Wins NMPA Clearance to Trial DR30206 – Tri‑Target PD‑L1/VEGF/TGF‑β Fusion Protein Advances into Stage III NSCLC Consolidation Therapy

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
Frontera Therapeutics Advances to Phase II with FT-003 for Diabetic Macular Edema
CompanyDrug

Frontera Therapeutics Advances to Phase II with FT-003 for Diabetic Macular Edema

Grand Pharmaceutical's GPN01768 Accepted for Review by NMPA for Demodex Blepharitis Treatment
CompanyDrug

Grand Pharmaceutical’s GPN01768 Accepted for Review by NMPA for Demodex Blepharitis Treatment

Grand Pharmaceutical Group Secures Licensing Agreement for CORXEL's Nasal Sprays in Greater China
CompanyDeals

Grand Pharmaceutical Group Secures Licensing Agreement for CORXEL’s Nasal Sprays in Greater China

EOSVISION Ltd Secures Series A Funding to Advance Ophthalmic Implant Development
CompanyDeals

EOSVISION Ltd Secures Series A Funding to Advance Ophthalmic Implant Development

Nona Biosciences Partners with Kodiak Sciences to Discover Multi-Target Ophthalmic Antibodies
CompanyDeals

Nona Biosciences Partners with Kodiak Sciences to Discover Multi-Target Ophthalmic Antibodies

Lee's Pharmaceutical Receives NMPA Approval for Generic Glaucoma Treatments
CompanyDrug

Lee’s Pharmaceutical Receives NMPA Approval for Generic Glaucoma Treatments

Eyebright Medical Technology Aims to Raise RMB 300 Million for Contact Lens Production Expansion
CompanyDeals

Eyebright Medical Technology Aims to Raise RMB 300 Million for Contact Lens Production Expansion

Ophthalmology Biotech Cloudbreak Pharma Inc. Pursues Hong Kong IPO
CompanyDeals

Ophthalmology Biotech Cloudbreak Pharma Inc. Pursues Hong Kong IPO

Show More